APA (7th ed.) Citation

E, K., G, P., MC, M., AD, W., A, J., HC, L., . . . G, M. (2026). Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis. Blood. https://doi.org/10.1182/blood.2025032099

Chicago Style (17th ed.) Citation

E, Kastritis, et al. "Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis." Blood 2026. https://doi.org/10.1182/blood.2025032099.

MLA (9th ed.) Citation

E, Kastritis, et al. "Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis." Blood, 2026, https://doi.org/10.1182/blood.2025032099.